MeSH tree: C01.150.252.819
Hidradenitis suppurativa, commonly referred to as HS, is a debilitating skin condition that causes chronic inflammation on the surface of the skin. This condition is characterized by painful bumps or boils that form under ...
Nov 20, 2024
0
31
University of Montreal and McGill University researchers in Canada have identified a significant association between hidradenitis suppurativa (HS) and higher risks of adverse pregnancy outcomes, as well as long-term health ...
In many countries in Africa, up to nine out of ten children suffer from a skin problem, and there are far too few local dermatologists. Artificial intelligence could help with diagnosis, but needs to be trained with the relevant ...
Oct 11, 2024
0
36
Aboriginal children living in remote communities have the highest rate of skin sores, or impetigo, in the world. Almost one in two have skin sores at any one time.
Oct 10, 2024
0
21
For patients with hidradenitis suppurativa (HS), bimekizumab is safe and efficacious over two years, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. ...
Oct 7, 2024
0
23
Lyme disease is one of the most prevalent insect-borne diseases in the country, with far more cases reported each year than other diseases carried by mosquitoes, fleas and ticks, such as West Nile virus.
Sep 26, 2024
0
47
A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic ...
Sep 25, 2024
0
26
The University of Cincinnati's Robert Van Haren was featured in a MedCentral article discussing recent research that found smoking cessation significantly reduced the risk of developing hidradenitis suppurativa, a non-contagious ...
Sep 5, 2024
0
34
Bimekizumab is well tolerated and produces clinically meaningful responses in patients with hidradenitis suppurativa, according to a study published online May 22 in The Lancet.
May 30, 2024
0
20
Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology.
Feb 21, 2024
0
27
